The biologic activity of MER-BCG in experimental systems and preliminary clinical studies
- 1 June 1977
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 4 (2) , 103-117
- https://doi.org/10.1016/s0305-7372(77)80008-x
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- MACROPHAGES v. CANCERThe Lancet, 1976
- Effect of treatment with the MER fraction of tubercle bacilli on hydrolytic lysozomal enzyme activity of mouse peritoneal macrophagesCellular Immunology, 1975
- Therapeutic effect of intratumoral injection of BCG and other substances in rats and miceInternational Journal of Cancer, 1975
- Cell walls of mycobacteria and related organisms; Chemistry and immunostimulant propertiesMolecular and Cellular Biochemistry, 1975
- BCG immunotherapy of rat tumours in athymic nude miceNature, 1975
- COLONY‐FORMING AND COLONY‐STIMULATING CELLS IN RELATION TO PROGNOSIS IN LEUKEMIAActa Medica Scandinavica, 1974
- Potentiation and modulation of the immune response of guinea pigs to poorly immunogenic protein-hapten conjugates by pretreatment with the MER fraction of attenuated tubercle bacilliCellular Immunology, 1973
- Control of Carcinogenesis: A Possible Role for the Activated MacrophageScience, 1972
- Mechanism of Immunologically Specific Killing of Tumour Cells by MacrophagesNature, 1972
- STUDIES ON THE HETEROLOGOUS IMMUNOGENICITY OF A METHANOL-INSOLUBLE FRACTION OF ATTENUATED TUBERCLE BACILLI (BCG)The Journal of Experimental Medicine, 1966